Bausch Health
BHC
#3619
Rank
HK$22.97 B
Marketcap
HK$62.59
Share price
-1.83%
Change (1 day)
-4.04%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -HK$20.80

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -HK$20.71. In 2022 the company made an earnings per share (EPS) of -HK$4.84 an increase over its 2021 EPS that were of -HK$20.72.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$20.80329.69%
2022-HK$4.84-76.64%
2021-HK$20.7268.45%
2020-HK$12.30-68.91%
2019-HK$39.56-57.11%
2018-HK$92.24-272.22%
2017HK$53.56-199.29%
2016-HK$53.94798.7%
2015-HK$6.00-128.31%
2014HK$21.20-204.62%
2013-HK$20.27602.7%
2012-HK$2.88-171.15%
2011HK$4.05-143.96%
2010-HK$9.22-206.57%
2009HK$8.65-11.2%
2008HK$9.742.46%
2007HK$9.51-7.58%
2006HK$10.29-14.29%
2005HK$12.0054%
2004HK$7.80-500%
2003-HK$1.95-141.67%
2002HK$4.68-4.76%
2001HK$4.91-175%
2000-HK$6.55-268%
1999HK$3.9014.94%
1998HK$3.3920.83%
1997HK$2.8153.83%
1996HK$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$7.80-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA